Clinical Study
Improvement of Adherence with Occlu-Pad Therapy for Pediatric Patients with Amblyopia
| | | Occlu-pad
n=72 (%) | Patching
n=66 (%) |
| | Male | 36 (50) | 36 (55) | | Female | 36 (50) | 30 (45) |
| | Age at enrollment | | | | 3 to < 5 years | 29 (40) | 24 (36) | | 5 to 7 years | 25 (34) | 20 (30) | | 7 to 9 years | 18 (25) | 22 (33) | | Mean ± SD | 5.5 ± 1.7 | 5.0 ± 1.5 |
| | Type of amblyopia | | | | Anisometropia | 35 (48) | 35 (53) | | Strabismus | 37 (51) | 31 (46) |
| | Maximum magnitude of tropia | | | | Deviation at distance measured by SPCT,Δ | | | | Orthotropic | 42(58) | 34(52) | | 1-9 | 12(17) | 14(21) | | 10>= | 18(25) | 18(27) |
| | Maximum magnitude of tropia | | | | Deviation at near measured by SPCT,Δ | | | | Orthotropic | 42(58) | 36(55) | | 1-9 | 8(11) | 18(27) | | 10>= | 22(31) | 12(18) |
| | Distance visual acuity in amblyopic eye | (LogMAR) | | | 1.3 to 1.0 | 22 (30) | 20 (30) | | 0.8 to 0.4 | 30 (41) | 26 (39) | | 0.3 to 0.15 | 20 (27) | 20 (30) | | Mean ± SD | 4.5 ± 1.7 | 4.2 ± 1.2 |
| | Distance visual acuity in fellow eye | (LogMAR) | | | 0.1 to 0.0 | 4 (5) | 6 (9) | | ≥ -0.1 | 68 (94) | 60 (90) | | Mean ± SD | -0.05 ± 0.1 | -0.05 ± 0.1 |
| | Refractive error in amblyopic eye (SE) | | | | 0 to < +4.00D | 15 (20) | 12 (18) | | +4.00D to < +7.00D | 41 (56) | 35 (53) | | ≥ +7.00D | 16 (22) | 19 (28) | | Mean ± SD (Diopter) | 5.5 ± 2.4 | 5.8 ± 1.6 |
| | Refractive error in amblyopic eye | (Astigmatism) | | | 0.00D to <0.50D | 21(29) | 21(32) | | 0.50D to <1.00D | 15(21) | 10(15) | | 1.00D to <1.50D | 16(22) | 18(27) | | ≥1.50 | 20(28) | 17(26) | | Mean ± SD(Diopter) | 1.0±0.9 | 1.2±1.0 |
| | Refractive error in fellow eye (SE) | | | | 0 to < +4.00D | 55(76) | 53(80) | | +4.00D to < +7.00D | 11(15) | 7(11) | | ≥ +7.00D | 6(8) | 6(9) | | Mean(SD)D | 2.8±3.0 | 3.1±3.9 |
| | Prior amblyopia treatment | | | | None | 60(83) | 66(91) | | Patching | 9(13) | 3(5) | | Atropine | 0(0) | 2(3) | | Patching and atropine | 3(4) | 1 |
|
|
